B7-2 Antibodies

Santa Cruz Biotechnology features a diverse variety of B7-2 monoclonal antibodies for immunology and cell biology research. B7-2 monoclonal antibodies are compatible with multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). B7-2, also known as CD86, plays a critical role in the activation of T cells and the regulation of immune responses. As a co-stimulatory molecule, B7-2 interacts with CD28 and CTLA-4 on T cells, influencing their proliferation and cytokine production. Understanding B7-2 function is essential for elucidating mechanisms of immune regulation and developing therapeutic strategies for autoimmune diseases and cancer. B7-2 expression patterns can be effectively mapped across different cell types and tissues using specific detection methods. Investigating B7-2 signaling pathways provides valuable insights into immune system modulation and potential therapeutic targets. Researchers worldwide rely on Santa Cruz Biotechnology monoclonal antibodies to advance scientific understanding of immune system regulation and disease mechanisms.